Abdul Nadir
Overview
Explore the profile of Abdul Nadir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malik A, Malik M, Javaid S, Qureshi S, Nadir A
Int J Obes (Lond)
. 2024 Oct;
49(1):54-62.
PMID: 39397157
Bariatric surgery is recommended for patients with unhealthy weight. Our study aim to compare and rank different bariatric surgical approaches in reducing weight parameters. We searched MEDLINE, Cochrane CENTRAL, Scopus,...
2.
Malik A, Nadir A, Malik M, Qureshi S, Adler D
Am J Ther
. 2024 Sep;
31(5):e560-e564.
PMID: 39292835
No abstract available.
3.
Malik A, Goyal H, Adler D, Javaid S, Malik M, Singh S, et al.
J Clin Gastroenterol
. 2024 Jul;
PMID: 39042479
Background: Microscopic colitis (MC) is an inflammatory bowel disease of autoimmune origin that causes chronic watery diarrhea. Medications, including budesonide, mesalamine, loperamide, cholestyramine, and bismuth subsalicylate, are first-line therapies. Meanwhile,...
4.
Khan S, Malik A, Qureshi S, Cohen B, Nadir A
Am J Case Rep
. 2024 Jul;
25:e943787.
PMID: 39014872
BACKGROUND Malignant peritoneal mesothelioma (MPM) is a rare, lethal tumor of serous membranes. The most common factor reported in association with MPM is asbestos exposure, while viral infections, genetic predisposition,...
5.
Malik A, Qureshi S, Nadir A, Malik M, Adler D
Indian J Gastroenterol
. 2024 Apr;
43(4):740-747.
PMID: 38564157
Methods: We searched Cochrane CENTRAL, PubMed, Web of Science, SCOPUS and Embase for related clinical trials about patients suffering from achalasia. The quality appraisal and assessment of risk of bias...
6.
Malik A, Nadir A, Javaid S, Qureshi S, Adler D
J Gastrointestin Liver Dis
. 2024 Mar;
33(1):137-138.
PMID: 38554430
No abstract available.
7.
Malik A, Malik M, Qureshi S, Nadir A
Ann Hepatol
. 2024 Mar;
29(4):101495.
PMID: 38460713
Introduction And Objectives: Hepatorenal syndrome (HRS) is a serious complication of cirrhosis treated with various medications. We aim to evaluate terlipressin and albumin's effectiveness and safety compared to albumin and...
8.
Turse E, Aboona M, Charley E, Forlemu A, Bowie T, Bhattarai B, et al.
J Hepatocell Carcinoma
. 2022 Jan;
9:1-11.
PMID: 35096683
Background: With the rising incidence of hepatocellular carcinoma (HCC), ongoing efforts should be focused on providing equitable and state-of-the-art care to patients. Purpose: The aim of this study was to...
9.
Seerat I, Mushtaq H, Rafiq M, Nadir A
Cureus
. 2020 Jun;
12(5):e7926.
PMID: 32494536
Objective This study evaluated the frequency of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and the associated horizontal risk factors in children being screened for viral hepatitis...
10.
Khan A, Nadir A, Mushtaq M, Junaid K, Khan A, Ali H, et al.
Infect Genet Evol
. 2020 May;
84:104372.
PMID: 32454246
Pakistan has second highest burden of hepatitis C virus (HCV) infected patients in the World. Little is known about the molecular epidemiology and risk factors for prevailing HCV genotypes in...